130 related articles for article (PubMed ID: 34004576)
1. New drug candidates for osteosarcoma: Drug repurposing based on gene expression signature.
Andrade RC; Boroni M; Amazonas MK; Vargas FR
Comput Biol Med; 2021 Jul; 134():104470. PubMed ID: 34004576
[TBL] [Abstract][Full Text] [Related]
2. Identifications of genetic differences between metastatic and non-metastatic osteosarcoma samples based on bioinformatics analysis.
Sun B; Wang F; Li M; Yang M
Med Oncol; 2015 May; 32(5):153. PubMed ID: 25832865
[TBL] [Abstract][Full Text] [Related]
3. Circular RNAs hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 are predicted to promote CADM1 expression by functioning as miRNAs sponge in human osteosarcoma.
Chen G; Wang Q; Yang Q; Li Z; Du Z; Ren M; Zhao H; Song Y; Zhang G
PLoS One; 2018; 13(8):e0202896. PubMed ID: 30153287
[TBL] [Abstract][Full Text] [Related]
4. Combined analysis of DNA methylation and gene expression profiles of osteosarcoma identified several prognosis signatures.
Tian W; Li Y; Zhang J; Li J; Gao J
Gene; 2018 Apr; 650():7-14. PubMed ID: 29407229
[TBL] [Abstract][Full Text] [Related]
5. Targeted Regulation of Osteoblasts and Osteoclasts in Osteosarcoma Patients by CSF3R Receptor Inhibition of Osteolysis Caused by Tumor Inflammation Based on Transcriptional Spectrum Analysis and Drug Library Screening.
Li Q; Shan J; Duan W; Chen Y
Recent Pat Anticancer Drug Discov; 2023 Oct; ():. PubMed ID: 37877147
[TBL] [Abstract][Full Text] [Related]
6. Potential target identification for osteosarcoma treatment: Gene expression re-analysis and drug repurposing.
Kamolphiwong R; Kanokwiroon K; Wongrin W; Chaiyawat P; Klangjorhor J; Settakorn J; Teeyakasem P; Sangphukieo A; Pruksakorn D
Gene; 2023 Mar; 856():147106. PubMed ID: 36513192
[TBL] [Abstract][Full Text] [Related]
7. Identification of differentially expressed genes in the development of osteosarcoma using RNA-seq.
Yang Y; Zhang Y; Qu X; Xia J; Li D; Li X; Wang Y; He Z; Li S; Zhou Y; Xie L; Yang Z
Oncotarget; 2016 Dec; 7(52):87194-87205. PubMed ID: 27888627
[TBL] [Abstract][Full Text] [Related]
8. Screening for metastatic osteosarcoma biomarkers with a DNA microarray.
Diao CY; Guo HB; Ouyang YR; Zhang HC; Liu LH; Bu J; Wang ZH; Xiao T
Asian Pac J Cancer Prev; 2014; 15(4):1817-22. PubMed ID: 24641415
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of AURKA/PLK4 in quiescence and senescence of osteosarcoma U2OS cells.
Xie XL; Zhu HX; Li YM; Chen DT; Fan TY
Cell Cycle; 2020 Apr; 19(8):884-894. PubMed ID: 32200684
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicle RNA Sequencing Reveals Dramatic Transcriptomic Alterations Between Metastatic and Primary Osteosarcoma in a Liquid Biopsy Approach.
Bao Q; Gong L; Wang J; Wen J; Shen Y; Zhang W
Ann Surg Oncol; 2018 Sep; 25(9):2642-2651. PubMed ID: 29981024
[TBL] [Abstract][Full Text] [Related]
11. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.
Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC
Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450
[TBL] [Abstract][Full Text] [Related]
12. Identification and functional analysis of differentially expressed genes related to metastatic osteosarcoma.
Niu F; Zhao S; Xu CY; Chen L; Ye L; Bi GB; Tian G; Gong P; Nie TH
Asian Pac J Cancer Prev; 2014; 15(24):10797-801. PubMed ID: 25605179
[TBL] [Abstract][Full Text] [Related]
13. miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control.
Novello C; Pazzaglia L; Cingolani C; Conti A; Quattrini I; Manara MC; Tognon M; Picci P; Benassi MS
Int J Oncol; 2013 Feb; 42(2):667-75. PubMed ID: 23229283
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic alterations in mesenchymal stem cells by osteosarcoma-derived extracellular vesicles.
Mannerström B; Kornilov R; Abu-Shahba AG; Chowdhury IM; Sinha S; Seppänen-Kaijansinkko R; Kaur S
Epigenetics; 2019 Apr; 14(4):352-364. PubMed ID: 30907225
[TBL] [Abstract][Full Text] [Related]
15. Advances in targeted therapy for osteosarcoma based on molecular classification.
Chen Y; Liu R; Wang W; Wang C; Zhang N; Shao X; He Q; Ying M
Pharmacol Res; 2021 Jul; 169():105684. PubMed ID: 34022396
[TBL] [Abstract][Full Text] [Related]
16. MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines.
Fenger JM; Roberts RD; Iwenofu OH; Bear MD; Zhang X; Couto JI; Modiano JF; Kisseberth WC; London CA
BMC Cancer; 2016 Oct; 16(1):784. PubMed ID: 27724924
[TBL] [Abstract][Full Text] [Related]
17. Identification of Pathogenic Genes and Transcription Factors in Osteosarcoma.
Yang C; Huang D; Ma C; Ren J; Fu L; Cheng C; Li B; Shi X
Pathol Oncol Res; 2020 Apr; 26(2):1041-1048. PubMed ID: 30982140
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
Zhu KP; Zhang CL; Shen GQ; Zhu ZS
Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
[TBL] [Abstract][Full Text] [Related]
19. Exploration and validation of downregulated microRNA-199a-3p, downstream messenger RNA targets and transcriptional regulation in osteosarcoma.
Huang WT; Liu AG; Cai KT; He RQ; Li Z; Wei QJ; Chen MY; Huang JY; Yan WY; Zhou H; Chen G; Ma J
Am J Transl Res; 2019; 11(12):7538-7554. PubMed ID: 31934299
[TBL] [Abstract][Full Text] [Related]
20. Exploring targeted therapy of osteosarcoma using proteomics data.
Chaiyawat P; Settakorn J; Sangsin A; Teeyakasem P; Klangjorhor J; Soongkhaw A; Pruksakorn D
Onco Targets Ther; 2017; 10():565-577. PubMed ID: 28203090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
